Earnings Look Back: Bristol-Myers Squibb Is Down 5.0% Since Reporting ... Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. By Mallory Stone. |
